Hershey Signals Long-Term Growth Plans but Valuation Remains Stretched

What happened

Hershey has communicated expectations for 2027 organic sales growth of 2% to 4% and a 50% increase in its product innovation pipeline, signaling management's focus on revitalizing growth after a period of severe margin compression. The company continues to face near-term headwinds from record cocoa costs and tariffs, which have sharply reduced gross and operating margins in 2025. While the new strategic targets are encouraging for long-term revenue potential, they do not address the near-term earnings trough or the premium valuation. The stock currently trades about 45% above a conservative discounted cash flow estimate, leaving little margin of safety. Consequently, the investment thesis remains a WAIT, pending evidence of sustainable margin normalization or a more attractive entry price.

Implication

The new 2027 growth target and increased innovation pipeline suggest management is investing for long-term competitiveness, but the near-term margin squeeze from cocoa and tariffs remains unresolved. Investors should track whether Hershey can achieve the guided growth without sacrificing profitability, and whether the innovation pipeline translates into tangible sales gains. The stock's premium multiple already prices in a successful recovery, so any disappointment could lead to multiple compression. Until margins show clear signs of normalizing and the valuation provides a wider margin of safety, long-term investors should remain patient. A more attractive entry point near the DCF anchor or evidence of structural margin improvement would warrant a shift to a potential buy.

Thesis delta

The thesis is unchanged. The new guidance for 2027 organic sales growth and the planned increase in innovation are modest positives for long-term revenue potential but do not materially alter the near-term margin recovery timeline or the overvaluation concern. The stock still trades significantly above conservative intrinsic value, and the core issues of commodity cost pressures and demand elasticity remain. Therefore, the WAIT stance is reaffirmed without adjustment.